首页 › 基金 › Jones Hill Capital LP › BCRX

Jones Hill Capital LP 对 BCRX 的持仓历史

BIOCRYST PHARMACEUTICALS INC · 医疗保健

Jones Hill Capital LP 在 Q3 2026 的 13F 申报中披露持有 BCRX(BIOCRYST PHARMACEUTICALS INC)7,083,300 股,市值约 US$59.0M,约占其申报组合的 10.01%,在其申报持仓中市值排名第 2 位。 Jones Hill Capital LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)7.08M 股
申报持仓市值$59.00M
组合权重10.01%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Jones Hill Capital LP 对 BCRX 的持仓演变

Jones Hill Capital LP 于 Q3 2026 首次披露 BCRX 持仓:7,083,300 股(约 US$59.0M)。

逐季持仓明细

季度股数金额变化
Q3 2026 7.08M $59.00M 新进

关于 BCRX 与 13F 数据

BCRX(BIOCRYST PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 45 只申报持有 BCRX,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$158.3M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$151.0M), TCG Crossover Management, LLC (US$110.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BCRX 的基金

查看 BCRX 的全部基金持有人 →

常见问题

How long has Jones Hill Capital LP held BCRX?

Jones Hill Capital LP has disclosed BCRX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Jones Hill Capital LP's current position in BCRX?

As of Q3 2026, Jones Hill Capital LP holds 7.08M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), valued at $59.00M, representing 10.01% of its reported portfolio and ranking #2.

Has Jones Hill Capital LP been buying or selling BCRX?

In the latest 13F filing (Q3 2026), Jones Hill Capital LP newly opened its position in BCRX.

Which other funds hold BCRX?

Other major institutional holders of BCRX include RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.